Appearance and Shape (20°C) | Solid |
---|---|
CAS RN | 162011-90-7 |
MDL number | MFCD00935806 |
Molecular weight | 314.36 |
Molecular Formula | C17H14O4S |
Product code | ICTR0206 |
PubChem Substance ID | 354335586 |
Purity/Analytical Methods | >98.0%(GC) |
Reaxys-RN | 8269007 |
Appearance | White to Yellow to Orange powder to crystal |
---|---|
Purity(GC) | min. 98.0 % |
Pictograms | |
---|---|
Hazard statement | H302 : Harmful if swallowed. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant P270 : Do not eat, drink or smoke when using this product P264 : Wash skin thoroughly after handling P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
Signal word | Warning |
RTECS# | LU5135000 |
---|
Life Science Biochemicals and Reagents Enzymes, Enzyme Inhibitors, Enzyme Substrates Cyclooxygenase (COX) [by Application] Enzyme Inhibitors [Biochemicals and Reagents] Enzyme Inhibitors [A to C] Cyclooxygenase (COX) Inhibitors Enzyme Inhibitors [P to Q] Prostaglandin H Synthetases 1 (COX-1) and 2 (COX-2) Inhibitors Enzyme Inhibitors by Enzyme Enzymes [by Application] Cyclooxygenase (COX) Inhibitors Pharmaceutical Ingredients (for Research and Experimental Use) Anti-inflammatory Ingredients (for Research and Experimental Use) Anti-rheumatoid Arthritis Ingredients (for Research and Experimental Use) Non-Steroidal Anti-Inflammatories (NSAIDs) Non-steroidal Anti-inflammatory Agents (NSAIDs) Cell Biology Immune System, Inflammation, Allergy Research Cyclooxygenase (COX) Inhibitors Pharmaceutical Development and Drug Discovery Research Pharmaceutical Ingredients (for Research and Experimental Use) Anti-inflammatory Ingredients (for Research and Experimental Use) Anti-rheumatoid Arthritis Ingredients (for Research and Experimental Use) Non-Steroidal Anti-Inflammatories (NSAIDs) Non-steroidal Anti-inflammatory Agents (NSAIDs)